Add to watchlist
Back

 

28942-01 - Lecture: Animal Experimentation for Regulatory Purposes 2 CP

Semester fall semester 2022
Course frequency Every fall sem.
Lecturers Mark Deurinck (mark.deurinck@unibas.ch, Assessor)
Content Why do we perform animal experiments? How do we perform them? Who is regulating theme? Are we working on alternative tests? We will be discussing the principles, regulations and ethics of non-clinical studies, study design and endpoints, interpretation and application of results, in drug development.
Lecturers will be joining us from industry and academia, on a much appreciated voluntary basis.

Program overview (chronological order may vary):
- Animal Experimentation for Regulatory Purposes: Introduction to the module
- Species-specific Effects in Toxicity: Understanding and extrapolation to humans
- Regulatory toxicology: Health hazard assessment of drugs in the frame of regulations
- Toxicology: Study types, dose, species, study duration; basic study protocol; technologies
- Safety Pharmacology: Cardiovascular endpoints and models used in drug development
- Haematology, Clinical Chemistry, Urinalysis: Basic principles
- Mode of action and biological targets: pharmacology and toxicology; human extrapolation
- In silico tools for development of biologics
- Regulatory Toxicology for pharmaceutical intermediates
- Reproductive Toxicology: Studies and interpretation of results for human risk assessment
- Ethics in Animal Experimentation and legal requirements
- Carcinogenicity studies and in vivo genotoxicity
- Risk assessment for patient safety in manufacturing, incl. case study
Learning objectives Understand scientific and regulatory background of preclinical animal studies conducted during development and registration of drugs and chemicals and the interpretation of data for human health risk assessment.
Bibliography Provided during the lecture period
Comments Film and sound recordings during the course are strictly forbidden (recorders may be confiscated)
Weblink Department of Pharmaceutical Sciences

 

Admission requirements Completed Bachelor degree
Course application
Language of instruction English
Use of digital media No specific media used

 

Interval Weekday Time Room
wöchentlich Wednesday 15.15-17.00 Biozentrum, Seminarraum U1.191

Dates

Date Time Room
Wednesday 21.09.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 28.09.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 05.10.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 12.10.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 19.10.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 26.10.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 02.11.2022 15.15-17.00 Pharmazentrum, Examination weeks
Wednesday 09.11.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 16.11.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 23.11.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 30.11.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 07.12.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 14.12.2022 15.15-17.00 Biozentrum, Seminarraum U1.191
Wednesday 21.12.2022 15.15-17.00 Pharmazentrum, Examination weeks
Modules Electives Master Science in Pharmacy: Recommendations (Master's Studies: Science in Pharmacy)
Module: Translating Pharmacology and Drug Safety to Humans (Master's Studies: Drug Sciences)
Assessment format continuous assessment
Assessment details Written examination at the end of the semester (multiple Choice, possibly some essay questions)
https://pharma.unibas.ch/en/education/assessments-and-credit-points/continuous-assessments/
Assessment registration/deregistration Reg.: course registration, dereg: cancel course registration
Repeat examination no repeat examination
Scale 1-6 0,5
Repeated registration as often as necessary
Responsible faculty Faculty of Science, studiendekanat-philnat@unibas.ch
Offered by Departement Pharmazeutische Wissenschaften

Back